approaching lenalidomide-refractory multiple myeloma: unmet needs and ongoing trials
Published 1 year ago • 99 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
3:59
addressing the unmet need for patients with lenalidomide-refractory multiple myeloma
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
0:55
the need to improve treatment options for patients with lenalidomide-refractory multiple myeloma
-
1:55
approaching and managing relapsed high-risk myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
13:19
using the immune system to fight multiple myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
4:48
unmet needs in unfit/frail patients with multiple myeloma
-
4:08
factors to consider when approaching r/r multiple myeloma
-
1:35
monoclonal antibodies for lenalidomide-refractory multiple myeloma
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
47:18
diagnosis and risk assessment in multiple myeloma
-
2:00
defining and treating high-risk multiple myeloma
-
1:22
an all-molecular diagnostic approach for myeloma
-
1:41
innovative treatment strategies for multiple myeloma
-
3:02
improving and streamlining clinical trials in multiple myeloma
-
5:39
identifying vulnerable patients with multiple myeloma
-
2:54
using whole genome sequencing to track early events in multiple myeloma
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
9:13
treatment selection and sequencing for multiple myeloma